British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

This summer, GSK cut its yearly vaccine sales projection on the back of a narrowed recommendation for adult respiratory syncytial virus (RSV) vaccines from the Centers for Disease Control and ...

GSK has revised its annual vaccine sales forecast following new guidance on RSV from the CDC. But new evidence offers new ...

In Singapore’s humid climate, where respiratory illnesses can spread year-round, respiratory syncytial virus (RSV) is emerging as a stealthy and significant threat. RSV is a highly contagious ...

Sanofi is shipping BEYFORTUS (nirsevimab-alip) 50mg and 100mg Injection doses in the US to private healthcare providers and to the Centers for Disease Control and Prevention for its Vaccines for ...

Pregnant women across Australia could be offered a free vaccine to protect their babies against respiratory syncytial virus (RSV) from next year. Health Minister Mark Butler has flagged the ...

Covid-19 levels in the United States are high and rising, flu season is approaching quickly, and RSV cases are already starting to tick up. Forecasts from the US Centers for Disease Control and ...

Nearly 5,000 people in Jersey are eligible for the new Respiratory Syncytial Virus (RSV) vaccine which is being rolled out on the island from today. RSV can cause lung infections including ...

The Centers for Disease Control and Prevention recommends adults 75 and older and those 60 and older at risk of respiratory diseases get a shot to protect against respiratory syncytial virus ...